At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 62 enrolled
Drug / intervention
Tolcapone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Tolcapone on Decision Making and Alcohol Intake Using a Laboratory Bar in Moderate to Heavy Social Drinkers
In Brief
A Phase 2 clinical trial evaluating Tolcapone and Placebo for Alcohol Abuse and Impulsive Behavior. Completed, enrolled 62 participants across 2 sites.
Detailed Summary
The purpose of this study is to determine the effects of tolcapone on decision making and alcohol intake using a laboratory bar (on-site alcohol self-administration) in alcohol drinkers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Abuse, Impulsive Behavior
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedApr 2016
Enrollment StartOct 2016
Primary CompletionSep 2019
Study CompletionNov 2019
TodayJul 2026
First PostedApr 15, 2016
Enrollment StartOct 1, 2016
Primary CompletionSep 1, 2019
Study CompletionNov 1, 2019
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 10.2 years ago
Interventions
Tolcaponedrug
Placebodrug